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Abstract
Massively parallel reporter assays (MPRAs) can measure the regulatory function of thousands of DNA sequences in a
single experiment. Despite growing popularity, MPRA studies are limited by a lack of a unified framework for analyzing
the resulting data. Here we present MPRAnalyze: a statistical framework for analyzing MPRA count data. Our model
leverages the unique structure of MPRA data to quantify the function of regulatory sequences, compare sequences’
activity across different conditions, and provide necessary flexibility in an evolving field. We demonstrate the accuracy
and applicability of MPRAnalyze on simulated and published data and compare it with existing methods.
Background
Understanding the function of the non-coding genome
poses one of the most significant and outstanding chal-
lenges following the completion of the human genome
project [1]. One critical function that is primarily asso-
ciated with non-coding regions is to regulate the tran-
scription of nearby genes by interaction with transcription
factors and other proteins and through recruitment of
the RNA polymerase complex [2, 3]. Two of the main
classes of regulatory regions consist of promoters (which
are proximal to the transcription start site of the respec-
tive gene) and enhancers (distal elements), both demon-
strated to harbor many disease-related mutations [4, 5].
The delineation of these critical regions on a genome-wide
scale has traditionally relied on chromatin-associated fea-
tures that are indicative of regulatory activity, such as
acetylation or methylation of certain residues along his-
tone tails [1]. However, this approach does not provide
direct evidence for regulatory activity, nor the dependence
of this putative activity on the cellular context or on the
presence of mutations.
Recent advances in reporter assays address this issue
in a set of procedures dubbed massively parallel reporter
assays (MPRAs) [6, 7]. In these assays, a synthetic DNA
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construct that contains a minimal transcriptional unit is
introduced into cells. Each such construct is generally
composed of a candidate regulatory sequence of interest,
a minimal promoter, and a unique DNA “barcode” that
can be transcribed. The candidate sequences are assumed
to be capable of regulating the transcription of the bar-
code sequence similarly to how a native sequence may
regulate the transcription of its target gene. The cells
then undergo RNA and DNA sequencing to measure both
RNA transcript counts and DNA construct counts, and
the RNA-to-DNA ratio is used to estimate the transcrip-
tion rate of every barcode. Relying on sequence-based
reporters leverages the vast combinatorial space of unique
sequences (instead of a limited set of fluorescent reporters
[8]), and utilizes next-generation sequencing to measure
the activity of thousands of putative regulatory sequences
in a single experiment. To ensure robustness, each candi-
date regulatory sequence is usually associated with several
barcodes (< 10 to over 100, depending on the study).
MPRAs can be used to address several important ques-
tions. In classification studies, MPRAs are used to identify
which putative regulatory regions are indeed inducing
transcription (albeit in a synthetic context) [9, 10]. In
allelic comparison studies, MPRAs are used to quantify
the effect that variations to the sequence of regulatory
regions may have on their ability to regulate transcription.
This approach is primarily utilized for studying the effect
of genetic polymorphisms that are observed in humans
[11–13], but also to explore more basic science questions
such as the effect of perturbing the sequence content,
spacing, or number of transcription factor binding sites
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[13–15]. In comparative studies,MPRAs are used to quan-
tify the dependence between the regulatory activity of
each sequence and the cellular context, comparing tis-
sues [16], cell lines [11], or other conditions of interest
[17]. A combination of two or more study types is also
possible through more complex experimental designs, for
example measuring the interaction between alleles and
conditions [12].
Despite growing popularity of MPRAs, most studies to
date rely on analysis approaches that either discount the
inherent noise in the data (e.g., taking an average ratio
across all barcodes) or designed for other data modal-
ities (such as DESeq2 [18], typically used for RNA-seq
data, whose underlying assumptions may not hold true
for MPRA). Other MPRA analysis methods only address
some of the types of questions MPRAs can address, such
as QuASAR-MPRA [19] and mpralm [20] that only per-
form comparative analyses, and rely on ratio-based sum-
mary statistics that limits the statistical power provided
in these experiments. To address this, we have devel-
opedMPRAnalyze—a statistical framework that leverages
information frommultiple barcodes to ensure robust anal-
ysis of MPRA data. In the following, we demonstrate the
use of MPRAnalyze for the three primary analysis tasks
listed above, and compare its performance to the exist-
ing approaches using a collection of published datasets.
MPRAnalyze is available as an R package through
Bioconductor [21].
Results
MPRA data is produced from two parallel procedures:
RNA-sequencing is used to measure the number of
transcripts produced from each barcode, and DNA-
sequencing is used to measure the number of construct
copies of each barcode. Thus for each barcode the ratio
of RNA to DNA can serve as a conceptual proxy for the
transcription rate [7]. However, both DNA and RNAmea-
surement procedures provide an approximate and noisy
estimation, an issue exacerbated by the unstable nature
of a ratio: minor differences in the counts themselves can
result in major shifts in the ratio, especially when deal-
ing with small numbers. This problem can be handled by
associating multiple barcodes with each sequence, pro-
viding multiple replicates within a single experiment and
a single sequencing library. This approach introduces an
additional problem of summarizing counts from multi-
ple barcodes to get a single transcription rate estimate
for a candidate regulatory sequence, which is made diffi-
cult since the efficiency of incorporation inside cells, while
theoretically uniform across the different constructs, has
a significant degree of variability in practice (Fig. 1a).
Two commonly used techniques of addressing this issue
are based on summary statistics: the aggregated ratio,
which is the ratio of the sum of RNA counts across
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. Although intuitive, both summary statis-
tics have inherent limitations. The aggregated ratio loses
the statistical power that multiple barcodes provide and
is often dominated by a minority of barcodes with high
counts, and the mean ratio is highly sensitive to noise, as
recently demonstrated in a paper by Myint and colleagues
[20]. A method to leverage the multiplicity of barcodes
in a robust manner is therefore needed to fully fulfill the
potential of these assays.
MPRAnalyze model
We introduce MPRAnalyze, a method for the analysis
of MPRA data that uses a graphical model to relate the
DNA and RNA counts, account for the uncertainty in both
libraries and leverage the unique structure and oppor-
tunities presented by MPRA data. Out model relies on
the assumption of a linear relationship between the RNA
counts and the corresponding DNA counts: RNA =
DNA×α, similar to ratio-based approaches, with α denot-
ing the transcription rate. Our framework comprises two
nested models: the DNA model, which estimates the
latent construct counts for the observed DNA counts, and
the RNAmodel, which uses the construct count estimates
from the DNA model and the observed RNA counts to
estimates the rate of transcription, α (Fig. 1b).
For each candidate regulatory sequence, the model
requires two vectors of observations: DNA counts d and
RNA counts r, where each observation is the number of
times a specific barcode, associated with this sequence,
was observed at the DNA and RNA levels respectively.
Additionally, we denote ˆd the vector of latent construct
counts (DNA) and ˆr the vector of latent transcript counts
(RNA). We assume that the latent construct counts, from
which the observed DNA counts are sampled, are gen-
erated by a gamma distribution. Second, we assume that
the conditional distribution of the RNA counts follows a
Poisson distribution. Formally:







These result in a closed-form negative binomial likelihood
for the RNA counts:
ˆr ∼ NB
(
μ = α · k
β
, ψ = k
)
(3)
The negative binomial distribution is a common approx-
imation of sequencing data due to the observed over-
dispersion [22], and indeed all datasets we examined have
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Fig. 1MPRAnalyze model properties and fit. a Distribution of construct abundances (DNA barcodes) across datasets, computed as the observed
barcode count + 1 for visualization purposes. b A graphical representation of the MPRAnalyze model. External covariates (e.g., conditions of interest,
batch effects, barcode effects) are design-dependent. Latent construct and transcript counts are related by the transcription rate α. c Goodness of fit
plots for both DNA and RNA libraries across datasets. Expected counts were extracted from the fitted GLMs. MPRAnalyze’s model fits MPRA data
well, with R2 > 0.86 across all datasets. Since the Kwasnieski data only has one replicate in the DNA library, the DNA model is able to reach a perfect
fit, in which case the DNA estimates used in the RNA model are identical to the original DNA counts
a quadratic relationship between the mean and the vari-
ance, which can be captured by a negative binomial. This
relationship is also observed for the DNA libraries, which
is expected of Gamma-distributed data if the distribution’s
shape parameter k ≈ 1 (Additional file 1: Figures S1, S3;
“Methods”).
Now, assume we have two conditions. In this case,
each barcode is measured twice (once in each condition),
and the model needs to relate these observations and
account for potential differences between them. MPR-
Analyze achieves this by assuming that the effects are
log-additive, and replacing the simple components of the
DNA estimate (ˆd) and the transcription rate estimate (α)
with generalized linear models (GLM) that enable easy
encoding of various relationships between experimental
factors. The model then becomes:
log








Here, SD, SR are external correction factors, used to
account for various technical effects such as library size
in the DNA and RNA data respectively. XD,XR are design
matrices for the DNA and RNA models, which encode
the experimental setup of the assay. For instance, in a two
condition settings, each matrix will include a column with
a 0/1 indicator corresponding to the first or second con-
dition respectively. The respective coefficients β and γ
will then capture the effect associated with the choice of
condition. Notably, the DNA design matrix XD will also
usually encode the identity of the barcode, so as to enable
per-barcode estimation of construct abundance. This is
not necessary for the RNA design matrix XR since we
assume that the barcodes are replicates that should have
a single estimate of the transcription rate. An illustrative
example is provided in Figure S2 (Additional file 1) and a
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formal description of the model is provided in Additional
file 2.
The model can be further extended to encode multi-
ple covariates, both quantitative and qualitative, and thus
support the common structure of MPRA experiments,
namely multiple barcodes per sequence, multiple repli-
cates or batches, and multiple conditions analyzed simul-
taneously. An important aspect of this flexibility is that it
supports “un-paired” datasets in which the DNA sequenc-
ing was performed on the pool of constructs, prior to
incorporation into cells [10–13]. In these cases, there
might not be separate DNA estimates for each condi-
tion being tested, in which case the conditions of interest
would only be modelled in the RNA design matrix and
excluded from the DNA model.
In summary, MPRAnalyze utilizes a model that
accounts for barcode specific effects and leverages them
for increased statistical power and robustness of estima-
tion. Since a standard for MPRA experimental design has
yet to be formed, the nested GLM construction provides
flexibility and is easily adjustable to changing experimen-
tal designs. Our model is also highly interpretable, allow-
ing for quantitative estimates of sequence activity to be
easily extracted, as well as differential activity to be tested
directly using established statistical tests. This framework
can explicitly leverage negative controls (sequences with
no expected regulatory function) when available, either
to establish the null distribution in classification analy-
ses or to correct for systemic bias in comparative analyses
(“Methods”).
Benchmark datasets
In the following sections, we investigate the performance
of MPRAnalyze in quantifying the transcriptional activity
of candidate regions, as well as in the three major analy-
sis tasks, namely—classification, cross-condition analysis,
and allelic comparisons. Finally, we evaluate MPRAnalyze
in a complex setup where we investigate both multiple
conditions and multiple alleles. We compare MPRAna-
lyze to the current set of tools and analysis methodologies,
using simulated data and a collection of public data sets.
These datasets were chosen for representing a diversity
of MPRA protocols (e.g., episomal or lentiviral integra-
tion, DNA sequencing pre- or post-transduction), study
focus (classification, comparative analyses, allelic com-
parisons), and experimental design (number of barcodes
per sequence, number of replicates). A summary of the
data sets and their properties is provided in Table 1.
Applying MPRAnalyze to these data, we found that the
model is able to provide a good fit (R2 > 0.86 for all
datasets, Fig. 1c), which is consistent with our distribu-
tional assumptions (Additional file 1: Figure S3).
Quantification
We set out to examine the properties of the estimate of
transcription rate generated by MPRAnalyze, denoted α
(alpha), and compare it to the ratio-based summary statis-
tics (i.e., mean of RNA-to-DNA ratios across all barcodes,
or alternatively, the ratio of means [henceforth referred to
as the aggregate ratio]).
Reassuringly, the three estimates are largely in agree-
ment (Pearson’s r > 0.9 across datasets, Additional file 1:
Figure S4). To further examine the accuracy of the esti-
mates, we used the negative control sequences included in
some of the datasets. These are assumed to have an iden-
tical transcription rate induced by the minimal promoter
included in each construct with no sequence-induced
activity. We examined the variance of the estimates on
these sets. In the Kwasnieski dataset, the limited num-
ber of barcodes (n = 4) is mitigated by high counts per
barcode (Fig. 1a), leading to all estimates having similarly
low variance. In the barcode-rich datasets (n ≥ 90), the
mean ratio is expectedly [20] the most variable, with α
being the most consistent in the Inoue-Kircher datasets
and comparably consistent to the aggregated ratio in
the Inoue-Kreimer dataset (Fig. 2a). These results sug-
gest that MPRAnalyze is estimating similar transcription
rates across the negative controls, as expected from this
collection.
We then explored the effect of the number of barcodes
on the estimates’ performance. Using the barcode-rich
datasets, barcodes were sampled at various rates and esti-
mates were recomputed for each sequence (3 independent
samples per sequence per barcode rate). Using the full-
Table 1 MPRA datasets used for evaluation of MPRAnalyze throughout the paper
Dataset Type of analysis Integration DNA sequencing #Sequences #Negative controls #Barcodes #Replicates
(DNA,RNA)
Kwasnieski [10] Quantification Episomal Pre-transduction 1200 568 4 1,4
Inoue-Kircher (epi) [9] Quantification Episomal Post-transduction 2338 102 100 3,3
Inoue-Kircher (chr) [9] Quantification Lentiviral Post-transduction 2338 102 100 3,3
Inoue-Kreimer [17] Comparative Lentiviral Post-transduction 2464 200 90 3,3
Mattioli [13] Allelic Comparison Episomal Pre-transduction 3960 0 26/80 1, 4/8
In the Mattioli data, multiple values indicate an asymmetric design: reference alleles were associated with 80 barcodes compared with 26 barcodes for alternative alleles, and
4 replicates were available for K562 cells compared with 8 in HepG2. For further details on each datasets, see “Methods”
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The variance measured among estimates of negative-control sequences in each dataset (these are assumed to have an identical transcription rate).
b–d Barcodes were sampled and quantification was recomputed based on the partial data to measure the effect of barcode number on estimate
performance [See “Methods” for further subsampling details]. Analyses were performed using the full-data estimate as the ground truth. e–gMPRA
data was simulated to provide an actual ground truth. In each case we measured the bias (estimate − truth) (b,e); the standard deviation(√
Var (estimate − truth)) (c,f); and the Spearman correlation between the estimates and the ground truth (d,g)
data estimates as the ground truth, we found
that down-sampling barcodes does not result in
a systemic bias in any of the estimates (Fig. 2b),
and all estimates showed reduced variance with
increased barcodes, with the mean ratio under-
performing the other two estimates, and α having a
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similar or lower variance than the aggregated ratio
(Fig. 2c).
In many cases, the goal of quantifying sequence activity
is to rank and compare different sequences, as in mutage-
nesis experiments. To compare the stability of the order-
ing of sequences, the Spearman correlation was computed
between the estimates in each sub-sample to the estimates
of the full data. Alpha has either similar or higher corre-
lation than both ratio-based estimates across datasets and
barcode abundance (Fig. 2d).
Since these analyses are limited by a lack of ground
truth, MPRA data was then simulated by generating
random coefficients and using the same nested GLM
construction as described above to generate samples.
To avoid biasing the results, samples were generated
with a log-normal noise model instead of the default
Gamma-Poisson convolutional model MPRAnalyze uses
(“Methods”). We generated 281 sequences with gradually
increasing transcription rates spanning a range of possible
values (from 0.2 to 3, in 0.01 steps), with three replicates
in each simulation. The analyses above were repeated with
the simulated data. We found that while the measured
bias was indeed not influenced by the number of bar-
codes, the mean ratio is substantially more biased than
both α and the aggregated ratio (Fig. 2e). Similar to the
real data results, we found α has lower variance than
both ratio-based estimates, and higher correlation with
the true transcription rates (Fig. 2f, g). We also simu-
lated data with varying number of replicates and found
that increasing the number of replicates has a similar
effect to increasing the number of barcodes, since both
parameters increase the effective sample size. With any
given number of barcodes, increasing the number of repli-
cates improved performance—the degree of improvement
decreased whenmore barcodes were available (Additional
file 1: Figure S5).
Overall, we found that α performs similarly or better
than both ratio-based estimators in terms of accuracy,
consistency, and robustness to missing data.
Classification
A common use case for MPRA is classification of active
sequences, which induce transcriptional activity. This is
commonly done by comparing the ratio-based estimates
of the assayed sequences to a control set of sequences
[9, 10], an approach that suffers from the summary statis-
tics’ sensitivity to noise and missing data, demonstrated
above, which in the context of classification leads to
decreased power and accuracy. Other studies performed
this analysis using DESeq2 [18], a differential expres-
sion analysis (DEA) method, by treating the DNA and
RNA libraries as two conditions and looking for signifi-
cant differences between the two [11]. In the following we
demonstrate that overall DEA methods either lack power
or are not well calibrated for MPRA data. More impor-
tantly, these methods rely on an implicit assumption that
the majority of features do not display differential behav-
ior, a valid assumption for RNA-seq that does not hold for
MPRA, in which the assayed sequences are often explic-
itly selected for their potential activity. This assumption
makes the results of DEA methods highly dependent on
experimental design and sequence selection.
MPRAnalyze performs classification of active
sequences by comparing the respective α estimates
against the null distribution of transcription rate induced
solely by the minimal promoter. The null is based on neg-
ative control sequences when available, and otherwise,
MPRAnalyze relies on a conservative assumption that
the mode of the distribution of the α values is the mode
of the null distribution and that values lower than the
mode are broadly generated by the null. These values are
therefore used to estimate the mean and variance of the
null distribution.
In both scenarios, the α value of each candidate
sequence is compared against the null distribution using
the median absolute deviation (MAD)—a variant of the
Z-score that is less sensitive to outliers. MPRAnalyze sup-
ports either a one-sided or two-sided test, allowing for
identification of inducing sequences (inducing transcrip-
tion beyond the minimal promoter levels) or repressive
sequences (repressing transcription to below the pro-
moter levels). A one-sided test was used to generate all
results presented in this paper.
ComparingmPRAnalyze with existingmethods
To assess the performance of MPRAnalyze in classifi-
cation analyses, we compared six methods: MPRAna-
lyze with and without negative controls; empirical p val-
ues computed using the two ratio-based estimates, and
DESeq2 in either full mode (each barcode as a separate
sample) or collapsed mode (each replicate as a sample,
taking the sum across barcodes within each replicate;
see “Methods”). Similarly to MPRAnalyze, DESeq2 was
applied using an asymmetric mode, namely focusing on
inducing sequences that have a higher signal in the RNA
library than in the DNA library.
We examined the fraction of sequences that were signif-
icantly active (FDR < 0.05) in each dataset, stratified by
group: negative controls, candidate sequences, and posi-
tive controls when available (Fig. 3a). As expected, empir-
ical p values from the ratio-based estimates show a clear
lack of power. Both DESeq2-collapsed and MPRAnalyze
without controls have inflated rates of false positives in
the Kwasnieski datasets (compared with the theoretically
expected 5% false discovery rate among the negative con-
trols set). When examining the results across all datasets,
we find that while MPRAnalyze and DESeq2 have overall
comparable results, both modes of MPRAnalyze achieve a
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Fig. 3 Classification analysis comparisons. a fraction of sequences identified as significantly active (BH-corrected P < 0.05) by method and class of
sequence. MPRAnalyze results both in control-based (red) and no-controls (orange) modes; empirical p values based on the mean ratio (blue) or
aggregated ratio (green); DESeq2 results in collapsed mode (barcodes are summed within each batch, purple) or full mode (full data, light blue).
Absolute number of active sequences is displayed on the bars. b Precision-Recall curve. Precision is based on performance on the negative controls,
Recall is based on the total population of sequences, assuming all candidates are active. Error bars are ± the standard deviation of these measures
across datasets. c Fraction of active sequences detected after re-running the analyses on 685 sequences from the Inoue-Kreimer dataset that were
identified as active by MPRAnalyze (regular mode) and both DESeq2 modes, and the 200 controls from the same dataset. MPRAnalyze recapitulates
the same results, finding that 100% of the candidates are active, whereas DESeq2 full only identifies 161 (23.5%) and DESeq2 collapsed completely
fails to identify any active sequences
better balance between sensitivity (identifying candidates
as active) and specificity (not identifying negative controls
as active) than both modes of DESeq2 (Fig. 3b).
Since the above analysis overlooks the overall statistical
behavior of the methods, we examined the full p value dis-
tribution of eachmethodwithin each dataset. Considering
multiple datasets, we found that both modes of MPRAn-
alyze, both ratio-based methods and DESeq2-full appear
well calibrated, whereas DESeq2-collapsed does not fol-
low the theoretical distribution of p values: a mixture of
uniform values (corresponding to non-active sequences
that follow the null distribution) and low values (active
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sequences for which the null is rejected) (Additional file 1:
Figure S6). Similar results were found when examining
the distribution over negative controls only (expected to
be uniform), with MPRAnalyze in the no-control mode
having some inflated values (assigning more low p val-
ues than expected), which emphasizes the importance
of using negative controls in classification studies (Addi-
tional file 1: Figure S7). Finally, we examined the distri-
bution over positive controls (only available in the Inoue-
Kircher datasets) and found that MPRAnalyze in both
modes has significantly higher statistical power, being
outperformed only by ill-calibrated DESEq2-collapsed
(Additional file 1: Figure S8). Overall, we found that
despite comparable rates of sequences found statistically
significant, the MPRAnalyze model is better calibrated to
MPRA data.
Caveats of usingmethods designed for differential expression
DESeq2 pools information across all features included in
the dataset (genes for RNA-seq, candidate enhancers for
MPRA), both in the library size correction and estimation
of the dispersion parameter. However, unlike genome-
wide assays such as RNA-seq, the set of assayed features
in MPRA experiments is curated according to the spe-
cific goals and context of the study. We hypothesized that
DESeq2-based classification would be highly dependent
on the sequences included in the analysis.We repeated the
classification analysis on the Inoue-Kreimer dataset using
only the 200 negative controls sequences and 685 can-
didate sequences that were previously classified as active
by MPRAnalyze and both modes of DESeq2. This sim-
ulated a scenario in which the data was generated in an
experiment that included fewer sequences. Confirming
our hypothesis, MPRAnalyze results remain unchanged
with all candidate sequences significantly active, whereas
DESeq2-full only classifies 161 (23.5%) of the sequences as
active and DESeq2-collapsed finds no active sequences at
all. This reveal an inherent limitation of using differential
expression methods such as DESEq2 for analyzing MPRA
data.
Comparative studies
Another common use for MPRAs is comparative stud-
ies, looking for differential transcription induced by a
putative regulatory sequence between different cell types,
stimuli, or other experimental covariates [11, 16]. More
complex experimental settings are also possible, e.g., using
MPRA to evaluate transcriptional activity over time as in
the Inoue-Kreimer data [17], or the interaction between
differential allele activity and the presence of a cer-
tain transcription factor, as performed by Ulirsch and
colleagues [12].
Here we use the Inoue-Kircher data to demonstrate that
MPRAnalyze is more statistically powerful than estab-
lish methods for analyzing comparative MPRA data, and
therefore enables discovery of more neuanced biological
signals, and that MPRAnalyze supports more complex
experimental designs that are not supported by previous
methods (e.g., temporal analysis).
Performing differential activity analysis in MPRAna-
lyze can be done in two ways: first, since MPRAnlyze
optimizes the model using likelihood maximization, any
single hypothesis that can be encoded in a generalized
linear model can be tested using a likelihood ratio test.
This includes complex hypotheses that can be captured
by interaction terms between covariates (e.g., cell type
and genetic background [12]). Additionally, in simple two-
condition designs, or in cases where multiple contrasts
are compared to a single reference (e.g., multiple different
stimuli compared against the unstimulated behavior), the
model coefficients can be extracted from the RNA model
and tested using a Wald test. While both options are sup-
ported in the implementation of MPRAnalyze, the results
in this paper are based on likelihood ratio testing.
When performing comparative analysis, it is impor-
tant to account for possible biases, such as those induced
by overall differences in the basal transcription rate. In
RNA-seq experiments, this issue is usually resolved via
library size correction [23], but with MPRA this is not
necessarily sufficient. This is because for the library size
to properly correspond to bias in the data, either the
vast majority of features must be non-differential, or
the differential signal must be symmetric. Neither of
these assumptions necessarily hold for MPRA data, as
they largely depend on the selection of the candidate
sequences. For instance, MPRA can be designed with
most sequences being more active in one condition than
in the other, and thus most sequences are indeed differ-
entially active. To address this issue, MPRAnalyze utilizes
negative controls in the data to define the null differ-
ential behavior. This is done by fitting a separate, joint
model for the controls, in which each control sequence
has a distinct DNA model but they all share a single
RNAmodel, reflecting the basal activity in each condition
(Methods).
Alternative methods have been developed to address
this or similar questions. QuASAR-MPRA [19] was
designed specifically for allelic comparisons and uses a
beta-binomial model and mpralm [20] which is a gen-
eral differential-activity tool designed for MPRA which
fits a linear model. Both methods use summary statis-
tics and do not include barcode-level information in their
model. Mpralm can use either the aggregated ratio or
the mean ratio as the statistic, and is therefore subject to
the limitations described above. QuASAR-MPRA, simi-
lar to MPRAnalyze, models the DNA and RNA separately,
but it does so using the sum of counts across all bar-
codes in each condition, collapsing the data into a single
measurement.
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ComparingmPRAnalyze with existingmethods
To compare these different methods, we used the Inoue-
Kreimer dataset and extended the subset of samples
we used to include both the 0 h and 72 h timepoints
(post neural induction of human embryonic stem cells
(hESC)). We then looked for sequences whose activity dif-
fered between the two time points, using MPRAnalyze,
mpralm (both aggregated ratio and mean ratio modes),
and QuASAR-MPRA (“Methods”). The distribution of
p values (Fig. 4a) shows that overall MPRAnalyze and
both modes of mpralm are well calibrated, following the
expected mixture of uniform values and low values among
candidates, and showing slight inflation but overall uni-
form behavior among the negative controls. Conversely,
QuASAR-MPRA is less calibrated on both candidates
and negative control sequences, recapitulating the results
described by Myint et al. [20]. Indeed, QuASAR-MPRA
only identified two candidates as significantly differential
(BH-corrected p values < 0.05).
Overall, we observe that the estimates of effect size
(log fold-change) are largely reproducible across meth-
ods (Pearson’s r > 0.84 across all pairs). In terms of
statistical power (Fig. 4b), we observe that MPRAnalyze
calls more sequences as significant compared to the other
methods.We further note that the FDR values ofMPRAn-
alyze are largely correlated with those of mpralm among
statistically significant candidates (Spearman correlation
> 0.63 for sequences MPRAnalyze calls differential) and
that the estimates of QuASAR-MPRA do not correlate
with the other two methods (consistent with the results
in Fig. 4a). Further examination of the results excluded
QuASAR-MPRA since it did not identify a sufficient num-
ber differential sequences.
We further examined the differential sequences, after
filtering the results to only include candidate sequences
that are classified as active in at least one of the conditions
(BH-corrected p < 0.05, using MPRAnalyze’s classifica-
tion method). Interestingly, mpralm in aggregate mode
finds a roughly balanced number of sequences that are
increasing (99) and decreasing (91) in activity (comparing
0 h to 72 h), and in mean mode finds more decreas-
ing (89) than increasing (49), while MPRAnalyze finds far
more increasing (351) than decreasing (115) sequences
(Fig. 4c). However, sequences in the Inoue-Kreimer study
were explicitly selected to correspond to increased activ-
ity over the course of differentiation (2037 [82%] of the
assayed sequences are genomic regions selected due to
their closest gene showing increased expression over dif-
ferentiation). Therefore, the imbalance in the results from
MPRAnalyze fits to the design of the experiment.
We then explored the set of candidates that were
detected by each method. To this end, we divided
the set of differentially active sequences into decreas-
ing and increasing activity (comparing 0 h to the 72
h time point), then within each set we tested for
over-representation of DNA binding motifs (hyperge-
ometric test, BH-corrected p < 0.05; “Methods”).
To narrow down the results, we examined the union
of top 15 most enriched transcription factor bind-
ing motifs by each method (Fig. 4d, Additional file 1:
Figure S9, Additional file 3: Table S1, Additional file 4:
Table S2).
Among decreasing-activity sequences, we find as
expected binding sites for two of the core pluripotent fac-
tors (NANOG, POU5F1). While these are captured by
all methods, we observe a higher significance with MPR-
Analyze. Among increasing-activity sequences, where the
methods have more profound differences, we find that
MPRAnalyze generally has lower fold-enrichment scores,
but compensates by a substantial increase in statistical
power. Overall, mpralm in mean mode does not detect
many of the enriched transcription factors found by
the other methods, with a total of 23 (compared with
106 and 195 found by mpralm aggregate and MPRAn-
alyze, respectively), and displays diminished statistical
power.
To ensure that these results are not simply explained
by the higher number of differential sequences detected
by MPRAnalyze, we also examined a consensus + noise
option, where the consensus set (sequences called dif-
ferential by all methods) was inflated with randomly
chosen sequences (taken from the remaining population)
to match the number of differential sequences called
by MPRAnalyze (“Methods”). We find that this simu-
lated inflation that does not reflect true biological sig-
nal does not explain the increased power displayed by
MPRAnalyze.
Notably, MPRAnalyze results are enriched for binding
sites for TEAD2 and NRF1, but results accourding to the
other methods do not contain such enrichment. Both fac-
tors have been implicated in neurogenesis by previous
studies [24, 25], and upon closer examination we found
that NRF1 binding sites have comparable fold-enrichment
in all methods (1.48 in MPRAnalyze, 1.39 in mpralm
aggregate and 1.45 in mpralm mean), but only pass the
statistical threshold with MPRAnalyze. In the other direc-
tion, we found thempralm results are enriched for binding
sites of MYF5 and GSX1, but not theMPRAnalyze results.
However, when examining the mRNA levels measured in
the corresponding time points, we found that both factors
have very low expression levels in the conditions in which
MPRA was conducted (Additional file 5: Table S3). These
levels are below their characteristic expression levels in
tissues they are known to be active in [26], making them
less attractive candidates for driving differential transcrip-
tion. Overall, MPRAnalyze identifies biological signal that
is consistent with the competing methods, with increased
statistical power, which allows for more nuanced results.
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Fig. 4 Comparative analysis results of comparing timepoint 0h to 72h in the Inoue-Kreimer dataset. a p value distributions of candidates (top) and
controls (bottom). QuASAR-MPRA is poorly calibrated, whereas MPRAnalyze and both mpralm modes follow the theoretical behavior (mixture of
uniform and low values). b Direct comparison of MPRAnalyze to competing methods. Top panels show the biological effect size (log fold-change);
Bottom panels show the statistical significance (BH-corrected p; dotted lines are 0.05 threshold). c Venn diagram for MPRAnalyze and mpralm (both
modes). The numbers in each area are (top) the total number of sequences in the area, and (bottom) the number of decreasing-activity sequences
(left) + and increasing-activity sequences (right). d Enrichment of transcription factor binding sites in differentially active sequences as determined
by each method. Solid line represents threshold of 0.05. (see “Methods” for further details)
Detecting temporal activity
Finally, we note that MPRAnalyze can be used on
the entire Inoue-Kreimer dataset, which consists of
seven time-points, to identify sequences whose activ-
ity changes over time. MPRAnalyze performs this anal-
ysis by comparing two models: the full model, which
allows for time-dependent activity; and the reduced
model, in which time-point factors are excluded, thereby
forcing a constant behavior across time-points (meth-
ods). This analysis cannot be performed by either of
the competing methods: QuASAR-MPRA only supports
two-condition comparisons, and mpralm only supports
coefficient-based hypothesis testing. We ran MPRAn-
alyze in this fashion and after filtering sequences to
only those that are active in at least one time-point
(FDR < 0.05, using MPRAnalyze to perform classifi-
cation analysis per time-point) MPRAnalyze finds 749
(28%) sequences that have temporal activity (methods,
FDR < 0.05). Reassuringly, of the 466 sequences iden-
tified as differential between the first and last time-
points, 420 (90.1%) are found to have overall temporal
activity.
We found that temporal sequences broadly tend to have
a smooth impulse-like activation pattern over time [27],
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whereas negative control sequences have less clear pat-
terns (Additional file 1: Figure S10). We then clustered
the temporal sequences (K-means with K = 4 on α val-
ues, z-normalized for each sequence) in order to group
sequences with a similar temporal behavior pattern, and
repeated the same binding site enrichment analysis as
above (Additional file 6: Table S4) for each cluster. As
evidence for the validity of our approach, we found that
the sequences that are active at the early time points
were indeed enriched for binding sites of core pluripotent
factors (NANOG, SOX2, POUF51), and that sequences
that are active later in the differentiation process were
enriched for binding sites of transcription factors known
to participate in neural differentiation (ATF2 [28], HES1
[29], GLI1, LEF [30]).
Allelic comparison
Many MPRA studies deal with quantifying the effect of
sequence variants on regulatory function. These stud-
ies, referred to here as allelic comparison studies, include
those that compare observed genetic variants to investi-
gate the regulatory effect of different alleles of a regulatory
sequence [12], as well as studies that deliberately change
a sequence to elucidate the regulatory grammar in a sys-
temic fashion [13]. While conceptually similar to compar-
ative analyses, allelic comparisons require different factors
to be considered. Two important differences are: (1) the
compared sequences (e.g., wild type and mutant allele)
come from the same sample and therefore a systemic bias
is less concerning than it is when comparing different
conditions, and (2) the different alleles being compared
are associated with different barcodes, in contrast with
condition-wise comparison in which barcodes are shared
between conditions.
To demonstrate the utility of MPRAnalyze in this sce-
nario, we used recently published data by Mattioli and
colleagues [13], who measured the effects of all pos-
sible single-nucleotide deletions were examined on 31
selected promoters. To this end, an MPRA was conducted
with all the deletion and corresponding wild type (WT)
sequences, where each deletion was associated with 26
barcodes and each WT sequence was associated with 80
barcodes. A single sample of the pre-transduction plas-
mids was sequenced to produce the DNA library. The
RNA samples were taken from two different tissues: eight
samples from the HepG2 cell line and four samples from
the K562 cell line. This asymmetrical experimental design
exemplifies the diverse nature of MPRA studies, and the
necessity of a flexible framework.
Using this dataset, we demonstrate that MPRAnalyze is
well calibrated and more statistically powerful than estab-
lished methods, and supports studying the interaction of
multiple conditions: in this case finding sequence variants
with cell-line specific functional effects.
ComparingmPRAnalyze with existingmethods
Similar to the comparative analysis described above, we
compared each deletion sequence with the correspond-
ing WT in each tissue separately, with all three meth-
ods: MPRAnalyze, mpralm (which only supports the
aggregated mode for allelic comparisons), and QuASAR-
MPRA.
When examining the p value distribution generated by
each method we find that MPRAnalyze and mpralm are
both better calibrated than QuASAR-MPRA (Fig. 5a-b).
Consistent with our previous results, all methods have
correlated estimates of biological effects (Fig. 5c–f). The
methods are better correlated in the HepG2 data com-
pared with the K562 data (correlations with MPRAnalyze:
Pearson’s r = 0.72 in K562 and 0.77 in HepG2 for mpralm,
and 0.78 in K562 and 0.96 in HepG2 for QuASAR), which
we hypothesized is due to the higher number of replicates
in the HepG2 data. When the comparison was repeated
using only four replicates of the HepG2 data, the cor-
relations between methods decreased (correlations with
MPRAnalyze: Pearson’s r = 0.63 for mpralm and 0.38 for
QuASAR, Additional file 1: Figure S11).
We then compared the effects estimated by each
method across cell lines. Overall, we find a high degree
of similarity in the effects of sequence perturbation
across cell lines—a finding supported by all the meth-
ods we considered (Fig. 5g–i). Looking more closely, we
find that mpralm and QuASAR-MPRA both find a sys-
temic skew towards stronger effects in K562, with 72.6%
and 63.1% of deletions having a more extreme log fold-
change value in K562 compared with HepG2 in mpralm
and QuASAR-MPRA, respectively, whereas MPRAnalyze
results are more balanced, with 49.8%. When compar-
ing statistical power, we again find that MPRAnalyze
can detect more deletions that significantly affect the
rate of transcription (FDR < 0.05). In HepG2, MPR-
Analyze finds 2855 (72%) deletions with a significant
effect, whereas mpralm finds 2710 (68.4%), with 2071
(52.2%) of the sequences significant in both; in K562,
MPRAnalyze finds 1230 (31%) significant deletions com-
pared with 360 (9%) found by mpralm, with 272 (6.8%)
significant in both. In both cell types, QuASAR-MPRA
does not find any significantly functional deletion. As
expected, due to the larger sample size, both MPRAna-
lyze and mpralm are more powerful in HepG2 compared
with K562.
Identifying variants with cell-line specific effects
Since the Mattioli study performed allelic comparisons
in two cell types, it can also be used for the iden-
tification of deletions that have a different effect in
HepG2 cells compared with K562 cells. With MPRAn-
alyze, it is possible to address this question directly,
testing the interaction between the tissue and the allele
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Fig. 5 Performance evaluation in allelic comparison. a,b p value density of the three evaluated methods in both cell lines. c–f logFC values between
methods in each cell type shows all methods find a similar biological signal. g–i logFC values between cell types for each method. Some differences
are expected, but overall values are highly correlated. j Schematic of the enrichment analysis, testing cell-line specific functional deletions for
enrichment of motifs that were gained or lost by those deletions. k, l results of motif enrichment analyses. Transcription Factors with significant
enrichment (FDR < 0.05) are labeled
covariates in the model. When performing this anal-
ysis, MPRAnalyze found 608 (15.3%) differential dele-
tions that had a different effect between cell types. For
example, the core promoter of the lncRNA gene DLEU1
has several functional deletions that are highly con-
cordant between cell types, and a single differentially
functional deletion in position 83, where the deletion
has a significantly larger effect in HepG2 (logFC =
−0.86) than in K562 (logFC = −0.13)(Additional file 1:
Figure S12).
To examine the biological implications of our results,
we followed the analysis performed by Mattioli and col-
leagues and identified transcription factor binding motifs
that are disturbed by the single nucleotide deletions.
Focusing only on functional deletions (i.e., deletions that
had any effect in one or both cell lines), we looked for
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DNA binding motifs whose disruptive deletions are over-
represented in the set of conditionally functional deletions
(i.e., deletions with significantly more effect in one cell
line vs. the other) (Fig. 5j). Overall, we found three sta-
tistically enriched (Hypgergeometric test, FDR < 0.05,
Methods) motifs in the cell type specific deletions (Fig. 5k,
l). Reassuringly, we found that K562-specific deletions
were enriched for motifs of the erythroid transcription
factor NF-E2. These results demonstrate the potential
utility of MPRAnalyze in addressing cases of complex and
possibly asymmetric experimental designs.
Discussion
Massively parallel reporter assays are a powerful tech-
nique for functional characterization of enhancer activ-
ity in a high-throughput manner. MPRAs can be used
to quantify the contribution made by non-coding DNA
elements, such as enhancers, to transcriptional activ-
ity in nearby genes [10]. It can be further extended
to evaluate differences in regulatory activity between
different alleles [12], elucidate regulatory grammar via
mutagenesis studies [13], and compare enhancer activ-
ity between conditions [9]. Complex experimental designs
can include interaction studies, where one is interested in
how sequence changes affect differential activity between
cellular conditions [12], or identifying temporal patterns
in time-course data [17].
Since MPRAs are still an actively developing tech-
nology, they often vary in experimental design. While
MPRAnalyze is flexible and can handle various study
designs, the method benefits from certain experimental
decisions that are generally recommended but not always
leveraged in other analyses. First, pairing the DNA and
RNA libraries by extracting DNA from the same post-
transduction libraries that the RNA libraries are extracted
from, avoids introducing further experimental noise into
the data and enables MPRAnalyze to better fit and relate
the two models to increase accuracy of estimating nui-
sance factors. Additionally, as demonstrated in our results,
increasing the number of available barcodes and repli-
cates can greatly reduce the measured noise and increase
performance of all methods, as seen in recent studies
[31, 32]. Finally, the inclusion of negative control
sequences allows explicit modeling of the null behav-
ior and avoids relying on assumptions that may bias the
results and prevent proper interpretation of them. The
curated nature of MPRA datasets makes negative controls
a valuable and often crucial aspect of properly interpreting
the results.
MPRAnalyze offers a robust statistical framework that
enables all major uses of MPRAs in a unified model. Our
model avoids relying on ratio-based summary statistics,
seeking to directly model the data as structured, follow-
ing a similar trend in other high throughput functional
assay analysis methods, such as recent methods devel-
oped for the analysis of deep mutational scanning data
[33–35]. MPRAnalyze models noise in both DNA and
RNA libraries and uses a nested GLM design to control
barcode-specific effects and leverage the multiplicity of
barcodes for increased statistical power. The method is
highly flexible and allows various complex study designs
to be tested in a straight-forward manner, including those
currently not supported by any established method. Addi-
tionally, MPRAnalyze avoids relying on population-level
properties in the analysis, instead leveraging negative con-
trols when available to establish null behaviors.
Methods
Dataset collection and processing
For all datasets included in this paper, we relied on the
pre-processing and filtering performed by the authors of
the original papers. This ensures that MPRAnalyze’s per-
formance isn’t reflecting any favorable processing steps we
chose.
For Kwasnieski, the study [10] measured the activity
of potential regulatory regions in K562 cells. Regions
were selected according to ENCODE annotations of four
groups: enhancers, weak enhancers, repressed enhancers,
enhancers active in ESCs. The repressed and ESC-
annotated enhancers were used as controls and were
excluded from the analysis after library size normalization
factors were computed. In addition to control classes, each
class had internal sets of scrambled sequences used as
negative controls, which were used as controls in our anal-
yses. Each sequences in this dataset was associated with
four barcodes. The DNA was sequenced before transduc-
tion and with a single replicate, while four replicates are
available for the RNA. While the sample size in this data
is very limited, this allowed for higher read counts to be
achieved, mitigating the loss of statistical power by getting
more reliable quantification of the counts.
For Inoue-Kircher, the study [9] compared activity in
HepG2 cells of liver enhancers that were either episomal
or chromosomally integrated using a lentivirus (lentiM-
PRA). While the study is comparative, the comparison
is not between biological conditions and the results are
therefore difficult to validate or interpret. We therefore
decided to use the data as two separate quantification
datasets. The datasets were analyzed together to bet-
ter account for batch and barcode-specific effects, and α
estimates were extracted from the joint model for each
condition separately. Negative control sequences were
generated by scrambling candidate sequences, and pos-
itive controls were sequences that have been previously
validated as having a regulatory function in these cells.
Each sequence was associated with 100 unique barcodes.
DNA was sequenced post-transduction. Both DNA and
RNA have three replicates.
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For Inoue-Kreimer, the study [17] identified enhancers
with temporal activity over the first 72 h after neural
induction. lentiMPRA was performed in 7 timepoints (0,
3, 6, 12, 24, 48, and 72 h after undiction). For the pur-
pose of our analysis, we used only the data from the first
timepoint in the quantification and classification analyses,
and timepoints 0 and 72 h for the comparative analy-
sis. Negative controls are scrambled candidate sequences.
Each sequence was associated with 90 barcodes. DNAwas
sequenced post-transduction. Both DNA and RNA have
three replicates.
For Mattioli, the study [13] compared WT sequences
containing core promoters of 31 long non-coding RNAs
(21 sequences), enhancer RNAs (5 sequences) and mes-
senger RNAs (5 sequences) with the same sequences
with single-nucleotide deletions. Each core promoter was
divided to 2 “tiles” to covermore of the putative regulatory
sequence, resulting in a total of 62WT sequences.MPRAs
were performed in both K562 and HepG2 cells, with vary-
ing number of replicates (4 in K562, 8 in HepG2). DNA
was sequenced pre-transduction, and in a single replicate
(used for both cell types).
Computing transcription rate estimates
All transcription rate estimates were computed for library
size normalized MPRA data, using upper quartile nor-
malization to compute size factors. MPRAnalyze’s α was
computed for each dataset using the quantification anal-
ysis (See Additional files). Across datasets, batch and
barcode-level effects were modelled in the nested DNA
model, but excluded from the RNA model design. This
allows MPRAnalyze to model nuisance effects but asserts
that all barcodes associated with a single sequence must
share the same transcription rate. Both ratio-based esti-
mates were computed using only barcodes with non-
zero DNA and RNA counts. So for each sequence:












DESeq2 was used as a method for classifying active
enhancers, by comparing the DNA and RNA libraries as
the two conditions being compared. DEseq2 was used in
two modes: the full mode included each barcode as sepa-
rate sample, and the collapsed mode took the sum across
barcodes within each batch as a sample. In full mode, a
single count was added to each observation to avoid issues
with DESeq2 library normalization scheme. The model
used within DESeq2 was a simple comparison model:
type, where type identifies DNA and RNA observations.
QuASAR-MPRA was used according to the documenta-
tion provided in the package. The betas.beta.binom value,
which is the logit transformation of the allelic skew, was
used as a proxy for log fold-change.
mpralm was used according to the documentation pro-
vided in the package. For allelic comparisons, while the
package vignette uses the sum across barcodes when
aggregating the counts, we used the mean across barcodes
instead, since the two compared alleles did not have the
same number of associated barcodes. Additionally, since
the package requires manual aggregation of barcodes in
this situation, only the aggregated mode of the model is
supported for this type of analysis.
Subsampling analysis
For the subsampling analysis, barcodes were sampled
down to varying levels (for Inoue-Kircher datasets: 15,
30, 45, 60, 75, and 90 out of the total 100 barcodes; for
Inoue-Kreimer: 15, 30, 45, 60, and 75 of the total 90 bar-
codes). The analysis uses three independent replicates of
this down-sampling process, so overall for each sequence,
we get a set of 3 × K estimates at various numbers of
available barcodes, where K = 6 for the Inoue-Kircher
datasets and K = 5 for Inoue-Kreimer. The analyses were
done on the entire down-sampled dataset in a single run
and included the original data as well as the reduced-
barcodes data, to neutralize any effect that the library size
correction might have on the estimates.
Simulating mPRA data
MPRA data was simulated by generating random coeffi-
cients for the nested GLM construction that MPRAnalyze
uses. The latent (true) DNA and RNA counts were gener-
ated directly from the model, then log-normal noise was



















































where K controls the intercept term for the construct
distribution, the variance of which is σ 20 ; σ 2batch, σ 2BC con-
trol the size of batch and barcode effects, respectively;
σ 2D, σ 2R determine the noise levels added to the data; and
nint is the nearest-integer function, using base R’s round
function. An implementation of this simulation process is
included in the MPRAnalyze package.
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Noise was generated using log-normal noise instead
of Gamma/Negative Binomial to avoid generating data
directly from MPRAnalyze’s model, which might bias the
results.
Simulated data in this manuscript was generated with
three batches, varying numbers of barcodes, K = 5, and
σ0 = σbatch = σBC = σD = σR = 0.5.
Transcription factor binding site enrichment analysis
The transcription factor binding site enrichment anal-
ysis was performed using the binary binding matrix
computed by Inoue and Kreimer et al. [17], with each
entry indicating the potential for binding (motif-based
binding prediction using Fimo [36], FDR < 10−4)
or overlap with transcription factor ChIP-seq peaks
from publicly available data [37, 38]. Enrichment
was calculated using a hypergeometric test, with all
binding motifs of a each transcription factors being
pooled together. A factor was deemed enriched if BH-
corrected p< 0.05. Enrichment scores were calculated as:
log2
(
fraction of differential sequences containing a binding site of the TF
fraction of total sequences containing a binding st of the TF
)
.
For the consensus + noise option, for each TF we cal-
culated the number of predicted binding sites in the
consensus set and in the remaining population. We then
added artificial biding sites to the consensus set, propor-
tional to their abundance in the remaining population,
to match the number of differential sequences called by
MPRAnalyze.
Temporal activity analysis
The analysis was performed by setting the full RNAmodel
to include both batch and time-course factors (∼ batch
+ time), and the reduced model to batch factors only (∼
batch). A Likelihood-ratio test is performed for statisti-
cal significance, and a sequence is deemed “temporal” if
BH-corrected p < 0.05. Heatmaps for visualization were
generated using the ComplexHeatmap R package [39].
Differential deletions analysis
To identify differential deletions (deletions that affect the
induced transcription rate in K562 differently than in
HepG2) in the Mattioli dataset we used an interaction
term in the RNA model design, encoding the interaction
between the cell type factor and the allele factor:
H0 :RNA ∼ Allele + CellType + Allele : CellType
H1 :RNA ∼ Allele + CellType
Then a standard likelihood ratio test was performed to
determine statistical significance. Since the DNA data has
a different design (a single replicate shared across all RNA
samples), that design only modeled for barcode specific
effects.
Differential deletion motif analysis
Once differential deletions were identified, we divided the
differential deletions to those that had a greater effect in
HepG2 or K562. For each cell type, we used the motif hits
curated by Mattioli and collegues, which rely on FIMO-
based [36] predicted binding scores, to associate each
deletion with differential motifs: motifs predicted in one
allele and not the other. If the deletion causes a decrease
in the induced transcription rate, we took the “lost” motifs
(predicted in WT, not in the deletion), and if the deletion
caused an increase, we took the “gained” motifs (predicted
in the deletion, not the WT). All motifs associated with
the same transcription factor were pooled. Enrichment
scores were calculated using a hypergeometric test, using
the total set of functional deletions as background (motifs
for these were acquired in the same fashion).
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